Formulations of abaloparatide, transdermal patches thereof, and uses thereof
US10568937B2 · kind B2 · utility
12Cited by
21References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 6, 2017 |
| Grant date | Feb 25, 2020 |
| Priority date | — |
| Expiry date | Apr 6, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are abaloparatide formulations for transdermal delivery of a therapeutically effective amount of abaloparatide, as well as transdermal patches prepared using these formulations, methods of preparing the disclosed formulations and patches, and methods of using these formulations and patches to treat osteoporosis, osteopenia, osteoarthritis, and/or bone fracture, improve bone mineral density (BMD), improve trabecular bone score (TBS), and treat, prevent, and/or reduce bone fractures.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.